Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Shoppers Drug Mart Q1 Profit Up; Declares Dividend - Quick Facts

Shoppers Drug Mart Corp. (SC.TO: Quote) reported that its first-quarter net earnings were C$119 million or C$0.56 per share, up from C$118 million or C$0.54 per share in the year ago quarter.

Third quarter sales were C$2.394 billion, an increase of 2.0% over the same period last year, driven by sales growth in both prescriptions and in the front of the store. On a same-store basis, total sales increased 1.5% during the quarter.

On average, analysts polled by Thomson Reuters expected the company to earn $0.57 per share on revenues of $2.41 billion. Analysts' estimates typically exclude special items.

The Company also announced that its Board of Directors has declared a dividend of 26.5 cents per common share, payable July 13, 2012 to shareholders of record as of the close of business on June 29, 2012.

Click here to receive FREE breaking news email alerts for Shoppers Drug Mart Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.